Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

TRDATRDA
9 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in ENTRADA THERAPEUTICS INC

JACOBS LEVY EQUITY MANAGEMENT, INC holds 303,459 shares of TRDA (ENTRADA THERAPEUTICS INC), worth $2.2M as of 2026-Q2. The position was decreased (-9.1% shares). TRDA represents 0.0% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$2.2M

Current Shares

303,459

Total Value Change

+$320,481

Total Shares Change

+169,215

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
303,459
-9.1%
$2.2M0.0%$7.36
0
2026-Q1
Decreased
333,914
-8.0%
$4.2M0.0%$11.85
0
2025-Q4
Increased
362,786
+14.9%
$3.7M0.0%$10.09
30
2025-Q3
Increased
315,810
+43.1%
$1.8M0.0%$5.84
35
2025-Q2
Increased
220,736
+4.7%
$1.5M0.0%$6.91
27
2025-Q1
Decreased
210,873
-0.9%
$1.9M0.0%$9.56
0
2024-Q4
Increased
212,717
+5.4%
$3.7M0.0%$17.37
28
2024-Q3
Increased
201,803
+50.3%
$3.2M0.0%$16.45
37
2024-Q2
New
134,244
-
$1.9M0.0%$14.25
36

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used